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Continuous ambulatory and continuous cycling peritoneal dialysis in
children. A report of the Southwest Pediatric Nephrology Study Group.
Continuous ambulatory pentoneal dialysis (CAPD) and continuous
cycling peritoneal dialysis (CCPD) have become acceptable methods of
treatment for children with endstage renal disease (ESRD). In this study
we have compared the effectiveness of these two modalities of pro-
longed dwell peritoneal dialysis in 82 children treated at home with
CAPD and/or CCPD for a mean of 10.2 months. Forty variables were
evaluated during 92 patient periods (63 CAPD, 29 CCPD). There was no
difference between the two groups with regard to sex, race, original
disease, duration of dialysis, or volume of dialysis fluid. The only
difference in biochemical profiles between the two groups was a higher
serum creatinine in CCPD patients due in part to this group's greater
age. The rate of peritonitis was not different (CAPD 1/4.6, CCPD 1/5.2
months), but the number of patient periods devoid of peritonitis was
greater in the CCPD group (14/29 vs. 17/63, P = 0.04). Growth velocity
index (GVI) and standard deviation scores (SD scores) were used to
evaluate growth in the total group and subsets according to age.
Overall GVI was 88% of expected and did not differ between PD groups
(CAPD 88% vs. CCPD 89%). There were no significant changes in SD
scores for growth during the course of prolonged dwell peritoneal
dialysis indicating that the children did not experience further deteriora-
tion in growth. Children less than 4 years of age also did not have
significant changes in SD scores. We conclude that CAPD and CCPD
provide acceptable and comparable modes of dialytic therapy for
children with ESRD.
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Dialyse péritonéale continue ambulatoire et recyclage continu chez des
enfants. Rapport du Southwest Pediatric Nephrology Study Group. La
dialyse péritonéale continue ambulatoire (CAPD) et La dialyse
péritonéale recyclage continu (CCPD) sont devenues des méthodes
acceptables chez les enfants en ESRD. Dans cette étude, nous avons
compare l'efficacité de ces deux modalités de dialyse péritonéale a
demeure prolongee chez 82 enfants traités a domicile par CAPD et/ou.
CCPD pendant 10,2 mois en moyenne. Quarante variables ont eté
évaluées pendant 92 périodes-malades (63 CAPD, 29 CCPD). Ii n'y
avait pas de difference entre les deux groupes quant au sexe, Ia race, Ia
maladie initiale, Ia durée de dialyse ou le volume de liquide de dialyse.
La seule difference dans les profils biochimiques entre les deux groupes
était une créatininémie plus élevCe chez les malades en CCPD, en partie
a cause du plus grand age de ce groupe. Le taux de péritonite n'était
pas different (CAPD 1/4,6, CCPD 1/5,2 mois), mais le nombre de
malades sans episode de péritonite était plus élevé dans le groupe
CCPD (14/29 contre 17/62, P= 0,04). L'index de vitesse de croissance
(GVI) et les scores de deviation standard (sD/Scores) ont ete utilisés
pour évaluer la croissance chez les enfants et les sous-groupes en
fonction de l'age. Globalement, GVI était 84% de la valeur attendue, et
ne différait pas entre les groupes PD (CAPD 88% contre CCPD 89%). II
n'existait pas de modification significative des scores de SD pour la
croissance au cours de la dialyse peritonéale a demeure prolongée,
indiquant que les enfants n'avaient pas eu de degradation
supplementaire de leur croissance. Les enfants âgés de moms de 4 ans
n'avaient pas non plus de changements significatifs des scores de SD.
Nous concluons que Ia CAPD et la CCPD constituent des modes
acceptables et comparables de traitement dialytique chez les enfants en
ESRD.
Although it is generally accepted that renal transplantation
provides the optimal therapy for children with endstage renal
disease [1, 2], there is still uncertainty regarding the most
suitable form of dialysis for children awaiting transplantation or
for chronic therapy in children in whom transplantation is either
not possible or unsuccessful. The therapeutic results of chronic
maintenance hemodialysis in children with endstage renal dis-
ease (ESRD) have been unsatisfactory because of poor toler-
ance of the procedure, complications of the intermittent nature
of the dialysis, and insufficient growth [2—7]. The recent devel-
opment of techniques using "prolonged dwell" peritoneal dialy-
sis, continuous ambulatory peritoneal dialysis (CAPD), and
continuous cycling peritoneal dialysis (CCPD), has received a
great deal of attention because of encouraging reports in adults
[8—10]. Their use in pediatrics is increasing, with the hope that
they may offer significant therapeutic advantages for children
with ESRD [11—131. However, publications describing experi-
ence with CAPD in children have involved only small numbers
of children with limited information on therapeutic benefit.
Even less information is available on CCPD in children.
To compare the relative benefits of CAPD and CCPD in
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Table 1. Clinical and laboratory variables evaluated in patients on CAPD and CCPD
(I) Dialysis type: CAPD, CCPD
(2) Sex
(3) Race
(4) Age dialysis begun
(5) Duration of dialytic therapy
(6) Type of catheter
(7) Method of placement: surgeon or nephrologist
(8) Dialysis vol/cycle, mi/kg(9) No. catheters/No, catheter problems
(10) No. episodes of peritonitis
(11) No. exit site infections
(12) Catheter life, months
(13) Frequency of peritonitis episodes
(14) Days of hospitalization for peritonitis
(15) Mean age of patient during dialysis period
(16) Height at onset
(17) Latest height
(18) Height during PD therapy(19) GVO = Growth velocity observed, z hi/pt mo(20) GVCA = Growth velocity expected based on chronologic age, months(21) GVI = growth velocity index.(GVI = GVO/GVCA)
(22) Hematocrit
(23) Serum creatinine
(24) Blood urea nitrogen
(25) Serum sodium
(26) Serum potassium
(27) Serum chloride
(28) Serum carbon dioxide content
(29) Serum calcium
(30) Serum phosphorus
(31) Serum alkaline phosphatase
(32) Serum albumin
(33) Total serum protein
(34) Serum cholesterol
(35) Serum triglycerides
(36) Serum glucose
(37) Serum parathyroid hormone
(38) Original diagnosis
(39) Diagnosis code—congenital versus acquired lesion
(40) Current treatment:
= Recovered function
2 = Died
3 = Transplant4 = CAPD
children with endstage renal disease, a multicenter collabora-
tive study was performed by members of the Southwest Pedi-
atric Nephrology Study Group. The major aims of our study
were:
• To compare the biochemical and hematologic profiles of a
large series of children treated at home with CAPD and
CCPD in 11 pediatric renal centers
• To compare rates and consequences of peritonitis in chil-
dren treated at home with the two modalities
• To evaluate growth in these children and to examine
variables which may influence the rate of growth.
Methods
Patient population
Patients with ESRD were entered into this retrospective
analysis of prolonged dwell peritoneal dialysis if they were 18
years of age or less and had received CAPD or CCPD at home
for a minimum of 3 months. Separate criteria were used for
patients in whom growth data were analyzed.
Acquisition of data
Data were obtained from 11 pediatric renal centers. Standard-
ized questionnaires were used for data acquisition on individual
patients maintained for 3 months or longer on prolonged dwell
peritoneal dialysis. Analysis was performed at the SPNSG
Central Office of 40 representative clinical and laboratory
variables shown in Table I. Specific attention was directed
toward the rate of peritonitis and the growth rates of children
receiving either CAPD or CCPD. The biochemical profiles were
performed in the clinical laboratories of each institution.
Definitions
Peritonitis was defined as the occurrence of fever, abdominal
pain, and/or cloudy peritoneal effluent, which necessitated the
use of intraperitoneal or parenteral antibiotics. This diagnosis,
by definition, includes both bacterial and chemical peritonitis.
All of the children were on home dialysis and some of the
cultures were performed in peripheral hospitals. Data were
obtained on the rates of peritonitis, exit site infections, days
hospitalized because of peritonitis, and catheter life expectancy
for each form of prolonged dwell PD.
Growth data
Growth data were obtained and analyzed on all children who
had been on peritoneal dialysis 6 months or longer. Children
over 14 years of age at the end of the study period were
excluded from this analysis. This age was arbitrarily chosen as
an age in children with chronic renal disease that would exclude
those entering or past puberty.
A growth velocity index was calculated on each child using
the formula:
GVI = Actual growth velocity of patient (GV) < 100 (1)
Normal growth velocity for
chronologic age (GVCA)
A standard deviation score (SD score) was calculated using the
formula:
Patient's height — height at 50th percentile for age (2)SD of height for age
Normal data were obtained from the National Center for Health
Statistics 10-State Survey [141. Chronologic age was used in
these calculations rather than bone age due to the variability in
interpretation of bone age between the different institutions. All
data were calculated on the basis of one chronological year of
growth. SD score at the beginning of peritoneal dialysis repre-
sents the pre-existing deviation from normal growth of the
children when they started peritoneal dialysis. The change in
growth rate was calculated by SD (SD1 — SD2). A positive LSD
would indicate the child grew at a more normal rate and
experienced accelerated growth during peritoneal dialysis.
Comparisons were made between males and females on CCPD
5 = CCPD
6 = IPD
7 = HD
560 Southwest Pediatric Nephroiogy Study Group
Overall
group CAPD CCPD
92 63 29
47:45
13:63:16
33:30
7:43:13
14:15
6:20:3
8.5 5.2 7.7 5.2 10.2 4.7
Overall CAPD CCPD
Obstructive uropathy 18% 16% 21%
Reflux nephropathy 7% 8% 7%
Renal hypoplasia/dysplasia 17% 17% 17%
Focal segmental
glomeruloscierosis 15% 13% 17%
Other glomerulopathy 23% 22% 24%
Miscellaneous/unknown 20% 24% 14%
and CAPD, between each modality of therapy, and between age
groups.
Statistical methods
The 40 variables listed in Table 1 were analyzed by a variety
of statistical methods including Student I tests, y2 analysis,
Spearman' s correlation testing, Pearson's correlation testing,
and Fisher's exact test (when appropriate). Statistical signifi-
cance was defined as a P value equal to or less than 0.05. The
results are expressed as the mean I SD in the text and tables.
Eighty-two children, each treated for a minimum of 3 months
with CAPD and/or CCPD, were evaluated. The 82 patients
experienced a total of 92 treatment periods, 63 periods of
CAPD, and 29 of CCPD. Demographic characteristics of the
patients are shown in Table 2. The sex and racial characteristics
did not differ between the two groups. Though the children
treated with CCPD were slightly older, this difference was not
statistically significant. There was no difference in the duration
of the treatment interval on each modality of prolonged dwell
peritoneal dialysis nor in the volume of dialysis solution used in
each cycle.
The original renal disorders that led to endstage renal disease
were comparable in the two treatment groups and are shown in
Table 3. In this study, the combination of obstructive uropathy,
refiux nephropathy, and renal dysplasia accounted for ap-
proximately 40% of the children on dialysis. Another 37% of the
patients had ESRD secondary to glomerular diseases.
Representative hematological and biochemical profiles of the
two subgroups and the overall population of patients are shown
in Table 4. There were no differences in the biochemical profiles
between children on CAPD and CCPD with the exception of the
serum creatinine which was somewhat higher in the CCPD
patients. The higher serum creatinine concentrations in the
patients on CCPD paralleled the increased age of this group of
patients, but we do not have data to indicate whether the higher
serum creatinine in patients on CCPD is the result of larger
muscle mass or decreased clearance efficiency. Ten children
received both CAPD and CCPD. There were no differences in
the hematological and biochemical profiles in this crossover
group.
Peritonitis
Growth
Growth data were analyzed on 53 children who were on
prolonged dwell peritoneal dialysis for at least 6 months, 34 on
CAPD, and 19 on CCPD. Growth velocity was not significantly
different between patients receiving the two modalities of
treatment (CAPD 0.46 0.61 cm/month; CCPD 0.48 0.40
cm/month). GVCA in patients receiving CAPD (0.58 0.24
cm/month) was somewhat higher than that occurring in patients
on CCPD (0.50 0.19 cm/month) because the CCPD popula-
tion was slightly older. Children starting prolonged dwell pen-
toneal dialysis were growing at a growth velocity index of 88
8% of expected and were 2.6 1.8 SD5 below normal for height
(Table 7). Weight gain was 75 18% of expected, and the
children were 1.5 1.2 SD5 below normal for weight at the start
of peritoneal dialysis. At the end of a mean of 1.0 0.6 years on
Table 2. CAPD versus CCPD: Patient population
Treatment periods,
number
Sex (M:F)
Race (B:W:Oa)
Age, years
Duration of treatment,
months
Volume per cycle,
mi/kg
10.2 6.9 9.8 7.1 11.1 6.5
a Black: White:Other.
Table 3. Original renal disorders of patients on CAPD and/or CCPD
42.3 18.0 41.8 17.8 43.3 18.7 The rate of peritonitis in the total population and in the two
of patients is shown in Table 5. The overall fre-
quency of peritonitis was one episode per 4.8 patient months
and there was no significant difference in the rate of peritonitis
observed between the CAPD and CCPD patient populations.
Also shown in this table is the number of days of hospitalization
per patient month which resulted from an episode of peritonitis.
Although an apparent difference between the number of days of
hospitalization is present, the data are skewed significantly by
one patient who had a prolonged hospitalization and the number
of days in the two groups is, in fact, not different statistically.
Catheter placement was performed by surgeons in most pa-
tients, and, although the catheter life tended to be longer in the
CCPD patients, this difference was not significant.
Ten of the children evaluated in this study were treated with
both CAPD and CCPD; CAPD was the first form of therapy in
seven patients and the second form in three patients. The total
number of peritonitis episodes in this subset of patients was not
significantly different for the two modalities of treatment
(CAPD, 1/6.3 patient months; CCPD, 1/6.6 patient months).
However, when the peritonitis rate was compared between the
first modality of dialysis and the second, a significant difference
was apparent. Twenty episodes of peritonitis occurred in 88
patient months during the first form of dialysis whereas only six
episodes occurred over 83 patient months in the second form.
Thus, the frequency of peritonitis was one episode per 4.4
patient months versus one episode per 14 patient months,
Results respectively.
In the 182 episodes of peritonitis that occurred in the patients
in this study, over one-third of the episodes were caused by
staphylococci (Table 6). Twenty-one percent of the episodes
appeared to be examples of sterile peritonitis," but the lack of
uniformity of culture methods makes this conclusion somewhat
tenuous.
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Table 4. Hematologic and biochemical profilesa of children on periods of CAPD or CCPD
No. of
treatment
periods Overall group CAPD CCPD
Hematocrit, % 88 24.5 5.8 24.7 6.4 24.1 4.2
Creatinine, mg/dl 83 8.5 4.2 7.7 4.2 10.1 38b
BUN, mg/dl 91 65.1 25.7 64.4 24.8 66.4 28.1
Na, mEqiliter 91 137.9 4.3 137.7 4.4 138.3 4.1
K, mEqiliter 92 4.4 1.0 4.4 1.0 4.5 1.0
Cl, mEqiliter 91 100.5 5.7 100.4 5.8 100.6 5.7
C02, mM/liter 90 23.1 3.9 23.0 4.3 23.4 3.1
Calcium, mgldl 91 9.5 1.1 9.4 1.2 9.8 0.9
Phosphorus, mg/dl 89 5.1 1.5 5.2 1.5 5.0 1.3
Alkaline phosphatase, lU/liter 72 328.9 329.9 289.6 205.9 394.2 465.3
Serum albumin, gIdi 64 3.3 0.7 3.4 0.7 3.2 0.6
Glucose, mg/dl 72 106.3 23.8 107.0 27.0 104.7 15.9
Triglycerides, mg/dl 47 287.3 152.0 307.7 142.2 265.0 157.3
Cholesterol, mg/dl 57 231.5 69.7 218.4 64.0 249.5 74.5
a These profiles are expressed as serum concentrations.l P < 0.05 between CAPD and CCPD.
Table 5. Rate of infection in children on CAPD or CCPD
Overall CAPD CCPD
Frequency of peritonitis,
no. months/episode 4.8 6.8 4.6 6.3 5.2 7.7
Days of hospitalization per
patient for peritonitis 9.3 18.4 7.7 5.2 3.4 9.9
Method of catheter
placement, nephrologist
vs. surgeon 23:68 13:50 10:18
Catheter life, months 7.4 5.3 6.5 4.3 10.1 6.8
Table 6. Micro-organisms identified during 182 episodes of peritonitis
Type Number Frequency %
Staphylococcus epidermidis 44 24
Staphylococcus aureus 21 12
Pseudomonas species 11 6
Escherichia co/i 7 4
Enterobacter species 5 3
Acinobacter species 4 2
Candida species 4 2
Other organisms 31 17
Negative cultures 37 20
No culture data reported 18 10
Total 182
prolonged dwell peritoneal dialysis, the children were growing
at the same rate and had the same SD scores. Thus, although
these children did not experience catch up growth during a year
on peritoneal dialysis, they did maintain their relative position
on the growth tables.
This series contained 38 children on prolonged dwell perito-
neal dialysis who were 5 years of age or older and 15 children
less than 5 years of age (Table 8). When the children less than
5 years of age were analyzed separately, their growth rate was
found to be 89% of expected, and their SD scores did not
decrease.
The growth data obtained on the patients are also depicted on
Tanner-Whitehouse growth charts (Figs. 1 and 2). Figure 1
shows the growth velocity that was observed in individual
females treated with either CAPD or CCPD. Although many
patients attained excellent growth, there were some in whom
minimal or no growth occurred. Figure 2 depicts similar data
from the males that were treated with each of the forms of
prolonged dwell peritoneal dialysis.
Correlations between growth and other variables
Percent of expected growth (GVI) in all the children on
prolonged dwell peritoneal dialysis and in patient subgroups on
CAPD and CCPD were analyzed for correlations between
biochemical and hematological variables. Patients who were
treated with CAPD showed a strong correlation between GVI
and serum phosphorus concentrations. Patients with a GVI less
than 80% had a mean serum phosphorus of 4.3 mgldl (N 25),
whereas patients with GVI greater than or equal to 80% had a
mean serum phosphorus of 5.7 mgldl (N = 18, P < 0.0001). A
significant correlation was seen also when GVI was compared
with BUN. Children older than 5 years of age with a GVI less
than 80% had a mean BUN of 45 17 mg/dl, while children
with a GVI greater than or equal to 80% had a BUN of 73 10
mg/dl (P = 0.009). Children with GVI less than 80% had a mean
serum creatinine of 11.5 mgldl, while children with a GVI
greater than 80% had a serum creatinine concentration of 8.3
mg/dl (P = 0.03).
Outcome of the patients
The current status of the children evaluated in this study is
shown in Table 9. There is a trend for an increasing percentage
of the children treated with prolonged dwell peritoneal dialysis
to receive CCPD. In addition, the table shows that 17 of the
patients received a renal transplant and 9 other patients died.
Five patients can be defined as failures of prolonged dwell
peritoneal dialysis because they returned to hemodialysis.
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Table 7. Comparison of growth data in 53 children receiving CAPD or CCPDa
CAPD (34) CCPD (19)
Variable Start End A Start End A P duff
Age, years 6.9 5.1 7.8 5.0 1.0 0.6 9.3 4.7 10.4 4.8
Height, cm 104.2 31.0 109,4 28.0 5.5 5.7 118.2 27.2 123.2 24.7
% Expected growth, height 88 8 88 8 — 89 7 88 7
SD scores, height —2.6 1.8 —2.7 1.8 —0.1 1.0 —2.4 1.6 —2.5 1.3
Weight, kg 19.4 13.2 21.2 12.9 1.9 2.6 27.2 14.3 29.2 13.6
% Expected growth, weight 75 18 74 19 — 81 23 79 19
SD scores, weight —1.5 1.2 —1.6 1.3 —0.2 0.8 —1.2 1.6 —1.1 1.4
1.1 0.6
5.0 3.9
—
—0.2 0.9
2.0 2.6
—
—0.02 0.7
NS
NS
NS
NS
NS
NS
NS
a The number in parentheses denotes how many children were on CAPD and CCPD, respectively.
Table 8. Comparison of growth by age in 53 children receiving prolonged dwell peritoneal dialysis
Children <5 years of age (N = 15) Children 5 years or older (N = 38)
Variable Start End A Start End A P
% Expected growth, height 90 9 89 8 — 88 8 87 7 — NS
SD scores, height —2.7 1.6 —2.8 1.8 —0.1 1.3 —2.5 1.8 —2.6 1.6 —0.1 0.8 NS
% Expected growth, weight 75 16 79 20 — 78 22 74 18 — 0.02
SD scores, weight —1.8 2.2 —1.9 2.0 0.2 1.2 —1.0 1.0 —1.2 1.0 0.2 0.6 NS
>-
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Fig. 1. Growth velocity in female children treated with prolonged dwell
peritoneal dialysis. Symbols: 0, CAPD; •, CCPD.
DiscusSion
The primary goal of the present study was to determine
whether CAPD and CCPD confer equivalent therapeutic ben-
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Fig. 2. Growth velocity in male children treated with prolonged dwell
peritoneal dialysis. Symbols are: 0, CAPD; U, CCPD.
efits to children with ESRD. Prior to the recent introduction of
prolonged dwell peritoneal dialysis as a mode of therapy for
ESRD patients, the three major treatment alternatives for such
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Table 9. Current status of patients on CAPD or CCPD
Overall CAPD CCPD
Recovered 1 2 0
Died 9 9 1
Transplant 17 14 3
CAPD 31 29 5
CCPD 19 6 18
IPD 0 0 0
HD 5 3 2
Total 82 63 29
a This table reflects the treatment modalities used at the end of the
study period for each of the 82 patients and following each of the 92
treatment periods.
children were renal transplantation, hemodialysis, or intermit-
tent peritoneal dialysis. It is accepted by most authorities that a
successful renal transplant is the optimal therapy for children
with ESRD [1, 21. However, the treatment available for interim
therapy of children awaiting transplantation, or for chronic
therapy in the event that renal transplantation is unsuccessful,
has been unsatisfactory for a number of reasons. In particular,
the growth that can be attained with either of these dialytic
modes is inferior to that seen with renal transplants [2—4,
15—181. The mechanisms involved in this growth retardation are
multiple and have been discussed in detail previously [2, 31. In
addition intermittent peritoneal dialysis and hemodialysis are
usually performed in dialysis units while CAPD and CCPD can
be performed at home.
Since CAPD and CCPD were first introduced, many reports
dealing with their relative efficacy in adults have been published
[8—101. Such studies suggest that the frequency of peritonitis
may be reduced by the use of CCPD but that the biochemical
profiles of the patients on the two forms of therapy are not
different. A number of pediatric studies evaluating CAPD have
been published and, in some cases, have compared the outcome
and acceptability of such treatment to that observed with
hemodialysis [5—71. In our study, CAPD and CCPD were found
to be equally satisfactory in the treatment of children with
ESRD.
The frequency of peritonitis in children treated with pro-
longed dwell peritoneal dialysis has been reported to be some-
what higher than that seen in a comparable series of adults [19,
20]. In our children, the rate of peritonitis was also high—
approximately one episode for every 5 patient months. This rate
was not different between children receiving either CAPD or
CCPD. As in other studies, our figures were skewed by oc-
casional patients who had multiple episodes of peritonitis but in
whom no alternative form of therapy was available. In this
regard 11 of 63 (17%) patients in the CAPD group and 4 of 29
(14%) patients in the CCPD group had more than three episodes
of peritonitis per year during the evaluation period. The orga-
nisms cultured from dialysis fluid in our children with peritonitis
were similar to the spectra that have been observed by other
authors and demonstrate the preponderance of skin pathogens
[19]. The relative paucity of gram negative organisms in our
study is comparable to that reported in other series [201. It is felt
that this experience is predictive of that obtained in large
numbers of patients on home prolonged dwell peritoneal dialy-
sis.
Our observations on ten patients who received both CAPD
and CCPD are of interest. The frequency of peritonitis was not
different between the two modes of dialysis in these patients,
however, when comparisons were made between the rate of
peritonitis during the first period of dialysis, regardless of
modality, versus the second period, a significantly higher inci-
dence of peritonitis was found during the first mode of treat-
ment, suggesting that increased knowledge and skill in perform-
ing the various procedures involved in prolonged dwell perito-
neal dialysis may result in a reduction in the frequency of
peritonitis.
The growth rate observed in children receiving either form of
prolonged dwell peritoneal dialysis was comparable to or better
than that reported previously by other authors in children on
hemodialysis. As in previous studies [5—7], we observed a wide
disparity in the growth achieved among the children (Figs. 1 and
2). Of importance was the finding that children less than 5 years
of age, which is the period of maximal growth, grew at a rate
comparable to that seen in the older children in this study. The
patients in whom severe bone abnormalities or inborn meta-
bolic disturbances prevented the attainment of any growth
obviously skew our results in a negative direction. However, in
a retrospective study such as this, it is not considered appropri-
ate to exclude patients on the basis of their underlying disease.
As is true in other retrospective studies, our growth data were
not optimal. The short period of time on dialysis until trans-
plantation led us to use 6 months of growth for our calculations.
There was no difference between growth measured after 6 or 12
months on dialysis. We chose to calculate growth using in-
crease in stature for chronological age. We felt the addition of
the variable of interpretation of bone age would further skew
our results [2]. Finally, we arbitrarily chose 14 years as the age
of onset of puberty in most children with endstage renal disease
[2]. All our children were 14 years old or less at the end of the
last period for growth data. Any prospective evaluation of
growth in such children should have well defined exceptions
before growth can be compared between two treatment groups
of this type.
The biochemical variables associated with improved growth,
that is, increased levels of BUN and serum phosphorus, appear
somewhat surprising on first consideration. This is particularly
true in view of the observation by Kohaut [11] that improved
growth in children on CAPD is associated with a reduction in
serum parathyroid hormone levels. However, the relevance of
our findings to Kohaut's study cannot be evaluated directly
since we were unable to determine the role of hyperpara-
thyroidism. Rather, the increased BUN and serum phosphorus
levels associated with higher growth rates seen in our children
probably represent improved nutritional status. Those children
ingesting adequate substrate grew more normally and have
higher BUN and phosphorus concentrations. Unfortunately,
due to the lack of uniformity of dietary observations within our
different centers, we were unable to make comparisons be-
tween the caloric and protein intakes and other parameters.
The rationale for cooperative studies of patients on dialysis
have been described elsewhere [211. The conclusions that may
be drawn from our cooperative study pertain to the comparison
of the two forms of prolonged dwell peritoneal dialysis pres-
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ently available for children with endstage renal disease. We
conclude that home dialysis using prolonged dwell peritoneal
dialysis is an acceptable modality of therapy for children with
endstage renal disease. Both CAPD and CCPD provide equiva-
lent biochemical and hematological profiles in children. It is
apparent from the high frequency of peritonitis that much
improvement is still necessary in use of these modalities in
children. Likewise, it is apparent that growth rates, though still
inadequate in some children, are equal to or better than growth
rates observed in children treated with hemodialysis, particu-
larly in children less than 4 years of age. Appropriate prospec-
tive studies should be performed to evaluate measures that may
reduce the number of episodes of peritonitis and may provide
further information about those variables that may improve
growth in such children. Renal transplantation will remain the
optimal therapy for children with endstage renal disease, but
prolonged dwell peritoneal dialysis has the potential for provid-
mg a satisfactory alternative when successful renal transplanta-
tion is not possible.
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